Neuroacanthocytosis Syndromes: The Clinical Perspective

The two very rare neurodegenerative diseases historically known as the “neuroacanthocytosis syndromes” are due to mutations of either VPS13A or XK. These are phenotypically similar disorders that affect primarily the basal ganglia and hence result in involuntary abnormal movements as well as neurops...

Full description

Saved in:
Bibliographic Details
Published in:Contact Vol. 6; p. 25152564231210339
Main Authors: Walker, Ruth H., Peikert, Kevin, Jung, Hans H., Hermann, Andreas, Danek, Adrian
Format: Journal Article
Language:English
Published: Los Angeles, CA SAGE Publications 01.01.2023
Sage Publications Ltd
SAGE Publishing
Subjects:
Abnormalities
Basal ganglia
Cell membranes
Chorea
Cognitive ability
Disorders
Ganglia
Lipids
Neurodegenerative diseases
Therapeutic applications
VPS13A
chorea
BLTP
acanthocytosis
XK
lipid
ISSN:2515-2564, 2515-2564
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The two very rare neurodegenerative diseases historically known as the “neuroacanthocytosis syndromes” are due to mutations of either VPS13A or XK. These are phenotypically similar disorders that affect primarily the basal ganglia and hence result in involuntary abnormal movements as well as neuropsychiatric and cognitive alterations. There are other shared features such as abnormalities of red cell membranes which result in acanthocytes, whose relationship to neurodegeneration is not yet known. Recent insights into the functions of these two proteins suggest dysfunction of lipid processing and trafficking at the subcellular level and may provide a mechanism for neuronal dysfunction and death, and potentially a target for therapeutic interventions.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:2515-2564
2515-2564
DOI:10.1177/25152564231210339